Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature.

Berger JS, Sallum RH, Katona B, Maya J, Ranganathan G, Xu Y, Mwamburi M.

Am Heart J. 2012 Aug;164(2):153-162.e5. doi: 10.1016/j.ahj.2012.04.001. Epub 2012 Jul 17. Review.

PMID:
22877800
2.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

3.

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

Warkentin AE, Donadini MP, Spencer FA, Lim W, Crowther M.

J Thromb Haemost. 2012 Apr;10(4):512-20. doi: 10.1111/j.1538-7836.2012.04635.x. Review.

4.

[Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases].

Preobrazhenskiń≠ DV, Sidorenko BA, Fettser DV, Batyraliev TA, Niiazova-Karben ZA, Besnili F.

Kardiologiia. 2010;50(5):73-6. Review. Russian.

PMID:
20831051
5.

The role of clopidogrel in the management of acute coronary syndromes.

Wodlinger AM, Pieper JA.

Clin Ther. 2003 Aug;25(8):2155-81. Review.

PMID:
14512126
6.

Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.

Reaume KT, Regal RE, Dorsch MP.

Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Review.

PMID:
18319394
7.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
8.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

9.

Aspirin for acute coronary syndromes: have we learned the correct dose yet?

Bainey KR, Mehta SR.

Curr Cardiol Rep. 2010 Jul;12(4):344-7. doi: 10.1007/s11886-010-0120-y. Review.

PMID:
20473591
10.

Outcomes of management of acute coronary syndrome in patients with congenital bleeding disorders: a single center experience and review of the literature.

Lim MY, Pruthi RK.

Thromb Res. 2012 Sep;130(3):316-22. doi: 10.1016/j.thromres.2012.02.050. Epub 2012 Mar 23. Review.

PMID:
22445429
11.

Antiplatelet intervention in acute coronary syndrome.

Arora RR, Rai F.

Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238. Review.

PMID:
19092648
12.

Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.

Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, Henderson R, Sudlow C, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(40):iii-iv, xv-xvi, 1-141. Review.

13.

Challenges in the adjudication of major bleeding events in acute coronary syndrome: a plea for a standardized approach and guidance to adjudication.

Kikkert WJ, Tijssen JG, Piek JJ, Henriques JP.

Eur Heart J. 2016 Apr 7;37(14):1104-12. doi: 10.1093/eurheartj/ehv584. Epub 2015 Nov 7. Review. No abstract available.

PMID:
26547224
Items per page

Supplemental Content

Write to the Help Desk